prostate cancer phenotype

Aliases

PCa, prostate cancer, prostate carcinoma

No related entities found.

Mentioned in (101)

Papers in which this entity is mentioned.

• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
• Artificial Intelligence agents for biological research: a survey. (2026)
• Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. (2026)
• Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
• Analysis of multi-condition single-cell data with latent embedding multivariate regression. (2025)
• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Functional analysis of cancer-associated germline risk variants. (2025)
• Genome-wide association testing beyond SNPs. (2025)
• Principles and methods for transferring polygenic risk scores across global populations. (2024)
• Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
• Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. (2024)
• Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology. (2024)
• The Application of Long-Read Sequencing to Cancer. (2024)
• A New Era of Data-Driven Cancer Research and Care: Opportunities and Challenges. (2024)
• Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. (2023)
• A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns. (2023)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
• GCparagon: evaluating and correcting GC biases in cell-free DNA at the fragment level. (2023)
• Predicting tumour content of liquid biopsies from cell-free DNA. (2023)
• Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
• Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• At the dawn: cell-free DNA fragmentomics and gene regulation. (2022)
• Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. (2022)
• Application of third-generation sequencing in cancer research. (2021)
• Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. (2021)
• Detection of somatic structural variants from short-read next-generation sequencing data. (2021)
• Evaluating the transcriptional fidelity of cancer models. (2021)
• Transcriptomic analyses of gastrulation-stage mouse embryos with differential susceptibility to alcohol. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes. (2021)
• Biologically informed deep neural network for prostate cancer discovery. (2021)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
• Polygenic risk scores: from research tools to clinical instruments. (2020)
• Structural variation in the sequencing era. (2020)
• DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. (2020)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Pan-cancer analysis of whole genomes. (2020)
• Systematic evaluation of differential splicing tools for RNA-seq studies. (2020)
• Inferring structural variant cancer cell fraction. (2020)
• Pan-cancer landscape of homologous recombination deficiency. (2020)
• Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. (2019)
• Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
• Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. (2019)
• Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing (2019)
• CNVScope: Visually Exploring Copy Number Aberrations in Cancer Genomes. (2019)
• Pan-cancer whole-genome analyses of metastatic solid tumours. (2019)
• Identifying simultaneous rearrangements in cancer genomes. (2018)
• Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. (2018)
• A fast detection of fusion genes from paired-end RNA-seq data. (2018)
• Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• Profiling Tumor Infiltrating Immune Cells with CIBERSORT. (2018)
• Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
• Tumor fraction in cell-free DNA as a biomarker in prostate cancer. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• Patterns and mechanisms of structural variations in human cancer. (2018)
• Copy number signatures and mutational processes in ovarian carcinoma. (2018)
• SVclone: inferring structural variant cancer cell fraction (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• CScape: a tool for predicting oncogenic single-point mutations in the cancer genome. (2017)
• Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
• Comprehensive Analysis of Hypermutation in Human Cancer. (2017)
• B lymphocytes and cancer: a love-hate relationship. (2016)
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
• Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
• Evolutionary Insights into RNA trans-Splicing in Vertebrates. (2016)
• Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
• DGIdb 2.0: mining clinically relevant drug-gene interactions. (2016)
• Integrative clinical genomics of advanced prostate cancer. (2015)
• What Happens When Children with Fetal Alcohol Spectrum Disorders Become Adults? (2015)
• The landscape of long noncoding RNAs in the human transcriptome. (2015)
• Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
• The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. (2015)
• Unraveling the clonal hierarchy of somatic genomic aberrations. (2014)
• RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
• Genome-wide analysis of noncoding regulatory mutations in cancer. (2014)
• rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. (2014)
• Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. (2014)
• Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
• PyClone: statistical inference of clonal population structure in cancer. (2014)
• Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer. (2013)
• Inferring tumour purity and stromal and immune cell admixture from expression data. (2013)
• Cancer genome landscapes. (2013)
• Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. (2013)
• Signatures of mutational processes in human cancer. (2013)
• Fusion genes and their discovery using high throughput sequencing. (2013)
• An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. (2013)
• Absolute quantification of somatic DNA alterations in human cancer. (2012)
• Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. (2012)
• Myeloid cells in tumor inflammation. (2012)
• Microsatellites with macro-influence in ewing sarcoma. (2012)
• Novel mutations target distinct subgroups of medulloblastoma. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)
• BRCA1 and BRCA2: different roles in a common pathway of genome protection. (2011)
• Outlier-Based Differential Expression Analysis in Proteomics Studies. (2011)
• Mechanisms and consequences of alternative polyadenylation. (2011)
• Integrative analysis of the melanoma transcriptome. (2010)
• 3' end mRNA processing: molecular mechanisms and implications for health and disease. (2008)

Merged raw entities (3)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.